Search results
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 3 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters via Yahoo Finance· 2 weeks agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 4 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 7 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 4 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
... in London Patent Battle over Covid-19 Vaccines In Legal Showdown - Moderna (NASDAQ:MRNA), Pfizer...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 weeks agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 7 hours agoPer Share standing at 15.67, this analysis seeks to delve deep into Moderna's valuation, encouraging investors to scrutinize the following insights. Moderna
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 19 hours agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna in a report released ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...